Exact Mass: 465.1581
Exact Mass Matches: 465.1581
Found 500 metabolites which its exact mass value is equals to given mass value 465.1581
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cisapride
In many countries (including Canada) cisapride has been either withdrawn or has had its indications limited due to reports about long QT syndrome due to cisapride, which predisposes to arrhythmias. The FDA issued a warning letter regarding this risk to health care professionals and patients. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].
Bacampicillin
Bacampicillin is a prodrug of ampicillin and is microbiologically inactive. It is absorbed following oral administration. During absorption from the gastrointestinal tract, bacampicillin is hydrolyzed by esterases present in the intestinal wall. It is microbiologically active as ampicillin, and exerts a bactericidal action through the inhibition of the biosynthesis of cell wall mucopeptides. It is used to cure infection of upper and lower respiratory tract; skin and soft tissue; urinary tract and acute uncomplicated gonococcal urethritis etc. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
cisapride
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].
(E)-Squamosamide
(E)-Squamosamide is found in fruits. (E)-Squamosamide is isolated from branches of Annona squamosa (sugar apple). Isolated from branches of Annona squamosa (sugar apple). (E)-Squamosamide is found in fruits.
(Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3R)-3-hydroxy-4-phenoxybut-1-enyl]-5-oxocyclopentyl]-N-methylsulfonylhept-5-enamide
Squamosamide
Trelanserin
2-[[2-[(3-Pyridinylcarbonyl)amino]benzoyl]amino]-3,4,5-trimethoxybenzoic acid methyl ester
N-(2-beta-D-glucopyranosyl-5-hydroxysalicyl)-5-hydroxyanthranilic acid methyl ester
Ala Cys Ser Trp
Ala Cys Trp Ser
Ala Asp Phe Asn
Ala Asp Asn Phe
Ala Phe Asp Asn
Ala Phe Asn Asp
Ala Met Met Asn
Ala Met Asn Met
Ala Asn Asp Phe
Ala Asn Phe Asp
Ala Asn Met Met
Ala Ser Cys Trp
Ala Ser Trp Cys
Ala Trp Cys Ser
Ala Trp Ser Cys
Cys Ala Ser Trp
Cys Ala Trp Ser
Cys Cys Ile Gln
Cys Cys Leu Gln
Cys Cys Gln Ile
Cys Cys Gln Leu
Cys Asp Lys Thr
Cys Asp Gln Thr
Cys Asp Thr Lys
Cys Asp Thr Gln
Cys Glu Lys Ser
Cys Glu Asn Thr
Cys Glu Gln Ser
Cys Glu Ser Lys
Cys Glu Ser Gln
Cys Glu Thr Asn
Cys Gly Met Arg
Cys Gly Arg Met
Cys Gly Thr Trp
Cys Gly Trp Thr
Cys Ile Cys Gln
Cys Ile Gln Cys
Cys Lys Asp Thr
Cys Lys Glu Ser
Cys Lys Ser Glu
Cys Lys Thr Asp
Cys Leu Cys Gln
Cys Leu Gln Cys
Cys Met Gly Arg
Cys Met Asn Val
Cys Met Arg Gly
Cys Met Val Asn
Cys Asn Glu Thr
Cys Asn Met Val
Cys Asn Thr Glu
Cys Asn Val Met
Cys Gln Cys Ile
Cys Gln Cys Leu
Cys Gln Asp Thr
Cys Gln Glu Ser
Cys Gln Ile Cys
Cys Gln Leu Cys
Cys Gln Ser Glu
Cys Gln Thr Asp
Cys Arg Gly Met
Cys Arg Met Gly
Cys Ser Ala Trp
Cys Ser Glu Lys
Cys Ser Glu Gln
Cys Ser Lys Glu
Cys Ser Gln Glu
Cys Ser Trp Ala
Cys Thr Asp Lys
Cys Thr Asp Gln
Cys Thr Glu Asn
Cys Thr Gly Trp
Cys Thr Lys Asp
Cys Thr Asn Glu
Cys Thr Gln Asp
Cys Thr Trp Gly
Cys Val Met Asn
Cys Val Asn Met
Cys Trp Ala Ser
Cys Trp Gly Thr
Cys Trp Ser Ala
Cys Trp Thr Gly
Asp Ala Phe Asn
Asp Ala Asn Phe
Asp Cys Lys Thr
Asp Cys Gln Thr
Asp Cys Thr Lys
Asp Cys Thr Gln
Asp Phe Ala Asn
Asp Phe Gly Gln
Asp Phe Asn Ala
Asp Phe Gln Gly
Asp Gly Phe Gln
Asp Gly Gln Phe
Asp Lys Cys Thr
Asp Lys Thr Cys
Asp Met Asn Ser
Asp Met Ser Asn
Asp Asn Ala Phe
Asp Asn Phe Ala
Asp Asn Met Ser
Asp Asn Ser Met
Asp Gln Cys Thr
Asp Gln Phe Gly
Asp Gln Gly Phe
Asp Gln Thr Cys
Asp Ser Met Asn
Asp Ser Asn Met
Asp Thr Cys Lys
Asp Thr Cys Gln
Asp Thr Lys Cys
Asp Thr Gln Cys
Glu Cys Lys Ser
Glu Cys Asn Thr
Glu Cys Gln Ser
Glu Cys Ser Lys
Glu Cys Ser Gln
Glu Cys Thr Asn
Glu Phe Gly Asn
Glu Phe Asn Gly
Glu Gly Phe Asn
Glu Gly Asn Phe
Glu Lys Cys Ser
Glu Lys Ser Cys
Glu Asn Cys Thr
Glu Asn Phe Gly
Glu Asn Gly Phe
Glu Asn Thr Cys
Glu Gln Cys Ser
Glu Gln Ser Cys
Glu Ser Cys Lys
Glu Ser Cys Gln
Glu Ser Lys Cys
Glu Ser Gln Cys
Glu Thr Cys Asn
Glu Thr Asn Cys
Phe Ala Asp Asn
Phe Ala Asn Asp
Phe Asp Ala Asn
Phe Asp Gly Gln
Phe Asp Asn Ala
Phe Asp Gln Gly
Phe Glu Gly Asn
Phe Glu Asn Gly
Phe Gly Asp Gln
Phe Gly Glu Asn
Phe Gly Asn Glu
Phe Gly Gln Asp
Phe Asn Ala Asp
Phe Asn Asp Ala
Phe Asn Glu Gly
Phe Asn Gly Glu
Phe Gln Asp Gly
Phe Gln Gly Asp
Gly Cys Met Arg
Gly Cys Arg Met
Gly Cys Thr Trp
Gly Cys Trp Thr
Gly Asp Phe Gln
Gly Asp Gln Phe
Gly Glu Phe Asn
Gly Glu Asn Phe
Gly Phe Asp Gln
Gly Phe Glu Asn
Gly Phe Asn Glu
Gly Phe Gln Asp
Gly Met Cys Arg
Gly Met Met Gln
Gly Met Gln Met
Gly Met Arg Cys
Gly Asn Glu Phe
Gly Asn Phe Glu
Gly Gln Asp Phe
Gly Gln Phe Asp
Gly Gln Met Met
Gly Arg Cys Met
Gly Arg Met Cys
Gly Thr Cys Trp
Gly Thr Trp Cys
Gly Trp Cys Thr
Gly Trp Thr Cys
Ile Cys Cys Gln
Ile Cys Gln Cys
Ile Gln Cys Cys
Lys Cys Asp Thr
Lys Cys Glu Ser
Lys Cys Ser Glu
Lys Cys Thr Asp
Lys Asp Cys Thr
Lys Asp Thr Cys
Lys Glu Cys Ser
Lys Glu Ser Cys
Lys Ser Cys Glu
Lys Ser Glu Cys
Lys Thr Cys Asp
Lys Thr Asp Cys
Leu Cys Cys Gln
Leu Cys Gln Cys
Leu Gln Cys Cys
Met Ala Met Asn
Met Ala Asn Met
Met Cys Gly Arg
Met Cys Asn Val
Met Cys Arg Gly
Met Cys Val Asn
Met Asp Asn Ser
Met Asp Ser Asn
Met Gly Cys Arg
Met Gly Met Gln
Met Gly Gln Met
Met Gly Arg Cys
Met Met Ala Asn
Met Met Gly Gln
Met Met Asn Ala
Met Met Gln Gly
Met Asn Ala Met
Met Asn Cys Val
Met Asn Asp Ser
Met Asn Met Ala
Met Asn Ser Asp
Met Asn Thr Thr
Met Asn Val Cys
Met Gln Gly Met
Met Gln Met Gly
Met Gln Ser Thr
Met Gln Thr Ser
Met Arg Cys Gly
Met Arg Gly Cys
Met Ser Asp Asn
Met Ser Asn Asp
Met Ser Gln Thr
Met Ser Thr Gln
Met Thr Asn Thr
Met Thr Gln Ser
Met Thr Ser Gln
Met Thr Thr Asn
Met Val Cys Asn
Met Val Asn Cys
Asn Ala Asp Phe
Asn Ala Phe Asp
Asn Ala Met Met
Asn Cys Glu Thr
Asn Cys Met Val
Asn Cys Thr Glu
Asn Cys Val Met
Asn Asp Ala Phe
Asn Asp Phe Ala
Asn Asp Met Ser
Asn Asp Ser Met
Asn Glu Cys Thr
Asn Glu Phe Gly
Asn Glu Gly Phe
Asn Glu Thr Cys
Asn Phe Ala Asp
Asn Phe Asp Ala
Asn Phe Glu Gly
Asn Phe Gly Glu
Asn Gly Glu Phe
Asn Gly Phe Glu
Asn Met Ala Met
Asn Met Cys Val
Asn Met Asp Ser
Asn Met Met Ala
Asn Met Ser Asp
Asn Met Thr Thr
Asn Met Val Cys
Asn Ser Asp Met
Asn Ser Met Asp
Asn Thr Cys Glu
Asn Thr Glu Cys
Asn Thr Met Thr
Asn Thr Thr Met
Asn Val Cys Met
Asn Val Met Cys
Gln Cys Cys Ile
Gln Cys Cys Leu
Gln Cys Asp Thr
Gln Cys Glu Ser
Gln Cys Ile Cys
Gln Cys Leu Cys
Gln Cys Ser Glu
Gln Cys Thr Asp
Gln Asp Cys Thr
Gln Asp Phe Gly
Gln Asp Gly Phe
Gln Asp Thr Cys
Gln Glu Cys Ser
Gln Glu Ser Cys
Gln Phe Asp Gly
Gln Phe Gly Asp
Gln Gly Asp Phe
Gln Gly Phe Asp
Gln Gly Met Met
Gln Ile Cys Cys
Gln Leu Cys Cys
Gln Met Gly Met
Gln Met Met Gly
Gln Met Ser Thr
Gln Met Thr Ser
Gln Ser Cys Glu
Gln Ser Glu Cys
Gln Ser Met Thr
Gln Ser Thr Met
Gln Thr Cys Asp
Gln Thr Asp Cys
Gln Thr Met Ser
Gln Thr Ser Met
Arg Cys Gly Met
Arg Cys Met Gly
Arg Gly Cys Met
Arg Gly Met Cys
Arg Met Cys Gly
Arg Met Gly Cys
Ser Ala Cys Trp
Ser Ala Trp Cys
Ser Cys Ala Trp
Ser Cys Glu Lys
Ser Cys Glu Gln
Ser Cys Gln Glu
Ser Cys Trp Ala
Ser Asp Met Asn
Ser Asp Asn Met
Ser Glu Cys Gln
Ser Glu Gln Cys
Ser Met Asp Asn
Ser Met Asn Asp
Ser Asn Asp Met
Ser Asn Met Asp
Ser Gln Cys Glu
Ser Gln Glu Cys
Ser Ser Ser Trp
Ser Ser Trp Ser
Ser Trp Ala Cys
Ser Trp Cys Ala
Ser Trp Ser Ser
Thr Cys Asp Gln
Thr Cys Glu Asn
Thr Cys Gly Trp
Thr Cys Asn Glu
Thr Cys Gln Asp
Thr Cys Trp Gly
Thr Asp Cys Gln
Thr Asp Gln Cys
Thr Glu Cys Asn
Thr Glu Asn Cys
Thr Gly Cys Trp
Thr Gly Trp Cys
Thr Asn Cys Glu
Thr Asn Glu Cys
Thr Gln Cys Asp
Thr Gln Asp Cys
Thr Trp Cys Gly
Thr Trp Gly Cys
Val Cys Met Asn
Val Cys Asn Met
Val Met Cys Asn
Val Met Asn Cys
Val Asn Cys Met
Val Asn Met Cys
Trp Ala Cys Ser
Trp Ala Ser Cys
Trp Cys Ala Ser
Trp Cys Gly Thr
Trp Cys Ser Ala
Trp Cys Thr Gly
Trp Gly Cys Thr
Trp Gly Thr Cys
Trp Ser Ala Cys
Trp Ser Cys Ala
Trp Ser Ser Ser
Trp Thr Cys Gly
Trp Thr Gly Cys
Sulprostone
G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AD - Prostaglandins D012102 - Reproductive Control Agents > D008600 - Menstruation-Inducing Agents D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents C78568 - Prostaglandin Analogue
Squamosamide
2-(4-Methoxybenzylidene)imino-2-deoxy-1,3,4,6-Tetra-O-acetyl-beta-D-glucopyranose
4-{4-[(3,5-Dimethyl-1,2-oxazol-4-yl)carbonyl]-1-piperazinyl}-N,N- diethyl-3-nitrobenzenesulfonamide
N-(3,5-DICHLORO-2-HYDROXY-4-METHYLPHENYL)-2-(2,4-DI-TERT-PENTYLPHENOXY)-ACETAMIDE
Teboquine
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
2-(1-(7-(4-BROMO-2,6-DIMETHYLPHENYL)-2,5,6-TRIMETHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDIN-4-YL)ACETONITRILE
Posizolid
D000890 - Anti-Infective Agents > D023303 - Oxazolidinones C254 - Anti-Infective Agent > C52588 - Antibacterial Agent
3-FLUORO-5-METHOXY-N-(2-(3-(PIPERAZIN-1-YLMETHYL)IMIDAZO[2,1-B]THIAZOL-6-YL)PHENYL)BENZAMIDE
(E)-Methyl 2-(2-Methoxy-5-((2′,4′,6′-triMethoxystyrylsulfonyl)Methyl)phenylamino)acetate
Haloperidol Lactate
C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
Bevonium metilsulfate
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
2-[(4-methyl-3-phenyl-3H-1,5-benzodiazepin-2-yl)amino]-2-oxoethyl 4-methylpiperazine-1-carbodithioate
(2R)-1-(Dimethylamino)-3-{4-[(6-{[2-fluoro-5-(trifluoromethyl)phenyl]amino}pyrimidin-4-YL)amino]phenoxy}propan-2-OL
(E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)hexan-1-imine
[[(E)-5-[(1S,2S,8aR)-2-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylpent-2-enoxy]-oxidophosphoryl] phosphate
[1-[(E)-cinnamyl]-2-methyl-imidazo[1,2-a]pyridin-4-ium-3-yl]-diphenyl-thioxo-phosphorane;bromide
Brasiliquinone A
A carbopolycyclic compound that is (3S)-3-ethyl-6,8-dihydroxy-3,4-dihydrotetraphene-1,7,12(2H)-trione substituted at position 8 by a 3-amino-2,3,6-trideoxy-alpha-L-ribo-hexopyranosyl group. It is isolated from the culture broth of Nocardia brasiliensis and exhibits antibacterial activity against Gram-positive bacteria. It is also active against the multiple drug-resistant P388/ADR tumour cells.
1-[[4-[(4-fluorophenyl)methyl]-5-thieno[3,2-b]pyrrolyl]-oxomethyl]-N-(2-furanylmethyl)-4-piperidinecarboxamide
N-[[4-[4-(4-fluorophenyl)piperazine-1-carbonyl]cyclohexyl]methyl]thiophene-2-sulfonamide
2-[6,7-dimethoxy-3-(3-methoxyphenyl)-2,4-dioxo-1-quinazolinyl]-N-(5-methyl-1H-pyrazol-3-yl)acetamide
4-[[3-Methoxy-4-[(4-nitrophenyl)methoxy]phenyl]-(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)methyl]-5-methyl-1,2-dihydropyrazol-3-one
N-cyclopentyl-2-[[4-methyl-5-[4-(4-morpholinylsulfonyl)phenyl]-1,2,4-triazol-3-yl]thio]acetamide
N-[(4-fluorophenyl)methyl]-2-[[4-(4-methoxyphenyl)-5-[(1-methyl-2-pyrrolyl)methyl]-1,2,4-triazol-3-yl]thio]acetamide
3-(Methylsulfamoyl)benzoic acid [2-[(9-ethyl-3-carbazolyl)amino]-2-oxoethyl] ester
2-[3-(2-furanylmethyl)-2-(4-methoxyphenyl)imino-4-oxo-5-thiazolidinyl]-N-(2-methoxyphenyl)acetamide
N-[4-[[anilino(sulfanylidene)methyl]amino]-2,5-diethoxyphenyl]-4-methoxybenzamide
2-[[2-(1-benzotriazolyl)-1-oxoethyl]-(thiophen-2-ylmethyl)amino]-2-(2-furanyl)-N-(3-methylbutyl)acetamide
(2E)-5-[(1S,2S,4aR,8aR)-2-hydroxy-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl diphosphate
(2E)-5-[(1R,2R,4aS,8aS)-1-hydroxy-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl diphosphate
4-fluoro-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
4-fluoro-N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(2-thiazolylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-chlorophenyl)methyl]acetamide
[(1S)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-cyclopropylmethanone
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
[(1R)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-cyclopropylmethanone
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(1,3-thiazol-2-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-chlorophenyl)methyl]acetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(1,3-thiazol-2-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-chlorophenyl)methyl]acetamide
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(1,3-thiazol-2-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-chlorophenyl)methyl]acetamide
4-fluoro-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
4-fluoro-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
1-[2-[(2R,5R,6S)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2S,5S,6R)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(2-thiazolylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-chlorophenyl)methyl]acetamide
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(2-thiazolylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-chlorophenyl)methyl]acetamide
4-fluoro-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
4-fluoro-N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
1-[2-[(2S,5R,6S)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2R,5R,6R)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2S,5S,6S)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2R,5S,6S)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2S,5R,6R)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(2-thiazolylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-chlorophenyl)methyl]acetamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(2-thiazolylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-chlorophenyl)methyl]acetamide
N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)-1-(N,N-dimethylglycyl)piperidine-4-carboxamide
1-ethoxycarbonyloxyethyl (2S,5S,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2Z)-N-Butyl-2-cyano-2-[(5E)-5-[[2-(difluoromethoxy)phenyl]methylidene]-3-(3-methoxypropyl)-4-oxo-1,3-thiazolidin-2-ylidene]acetamide
Propulsid
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].
Bacampicillin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum A penicillanic acid ester that is the 1-ethoxycarbonyloxyethyl ester of ampicillin. It is a semi-synthetic, microbiologically inactive prodrug of ampicillin. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
PI3K/AKT-IN-1
PI3K/AKT-IN-1 is an effective PI3K/AKT dual inhibitor (IC50 of 6.99, 4.01 and 3.36 μM for PI3Kγ, PI3Kδ and AKT, respectively). PI3K/AKT-IN-1 has anticancer activity and acts by inhibiting PI3K/AKT axis and inducing caspase 3 dependent apoptosis[1].